Merck Institute for Science Education-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

    New England Journal of Medicine, Vol. 376, Núm. 4, pp. 305-317